gsb-package: Group Sequential Bayesian Design

Description Details Author(s) References See Also

Description

The gsbDesign package allows to evaluate the operating characteristics for a group sequential design with Bayesian success/futility criteria and prior information. A clinical trial with two arms, a normal endpoint and an arbitrary number of interim analyses can be evaluated. The success and futility criteria at each interim analysis are based on the posterior distribution for the true treatment difference (delta). An arbitrary number of success and futility criteria can be specified at each interim analysis. The success criteria are of the form:

P( δ > ds | data ) > ps

And the futility criteria are of the form:

P( δ < df | data ) > pf

Here ds and df are user-specified effect thresholds, and ps and pf are user-defined probability thresholds.
Prior information can either be specified for the true treatment difference (delta), or for the true effects in the two treatment arms. Only normal prior distributions can be used. In all cases informative priors are specified in terms of a mean and an effective sample size defined relative to sigma.
The user also has to specify the number of patients for each stage of the group sequential design, and the standard deviation (sigma) of the endpoint (assumed to be known).
The operating characteristics are either evaluated for a user-specified grid of true treatment differences, or for a grid or set of true treatment means for the two arms. The operating characteristics of main interest are the probabilities of success and futility at each interim analysis, and the expected sample size.
The main function of the package is gsb(). More detailed information can be found in the help of function gsb().

Details

Package: gsbDesign
Type: Package
Version: 1.0-2
Date: 2021-10-02
License: GNU General Public License >=3
LazyLoad: yes

Author(s)

Florian Gerber <florian.gerber@math.uzh.ch>, Thomas Gsponer

References

See Also

gsb


gsbDesign documentation built on Oct. 4, 2021, 9:07 a.m.